Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million
07/05/2026 21:01
May 07 (Reuters) - Maravai LifeSciences Q1 net income USD -6.4 million. Q1 adjusted EBITDA USD 20.3 million vs. IBES estimate USD 4.04 million outlook FY adjusted EBITDA USD 30-32 million vs. IBES estimate USD 18.2 million outlook FY revenue USD 205-215 million vs. IBES estimate USD 204.9 million
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million